Eosinophil Counts, FeNO May Predict Asthma, COPD Exacerbations

• by Debbie Bunch

• June 15, 2026

Inhaler Utilization Differs According to Race, Economic Factors

• by Debbie Bunch

• June 1, 2026

FDA Expands Afrezza to Pediatric Diabetes

The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.

• by Kathryn Wighton

• May 29, 2026

• 3 min

The evolving role of regulatory T cells in pulmonary diseases: immunomodulatory mechanisms and translational directions revealed by bibliometric analysis

• by Qiuxia Wang, Jianfeng Jiang, Huici Yao, Ying Zhu

• June 9, 2026